A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Fluorescent Probes for Ecto-5 '-nucleotidase (CD73)




TekijätSchmies CC, Rolshoven G, Idris RM, Losenkova K, Renn C, Schakel L, Al-Hroub H, Wang YL, Garofano F, Schmidt-Wolf IGH, Zimmermann H, Yegutkin GG, Muller CE

KustantajaAMER CHEMICAL SOC

Julkaisuvuosi2020

JournalACS Medicinal Chemistry Letters

Tietokannassa oleva lehden nimiACS MEDICINAL CHEMISTRY LETTERS

Lehden akronyymiACS MED CHEM LETT

Vuosikerta11

Numero11

Aloitussivu2253

Lopetussivu2260

Sivujen määrä8

ISSN1948-5875

eISSN1948-5875

DOIhttps://doi.org/10.1021/acsmedchemlett.0c00391


Tiivistelmä
Ecto-5'-nucleotidase (CD73) catalyzes the hydrolysis of AMP to anti-inflammatory, immunosuppressive adenosine. It is expressed on vascular endothelial, epithelial, and also numerous cancer cells where it strongly contributes to an immunosuppressive microenvironment. In the present study we designed and synthesized fluorescent-labeled CD73 inhibitors with low nanomolar affinity and high selectivity based on N-6-benzyl-alpha,beta-methylene-ADP (PSB-12379) as a lead structure. Fluorescein was attached to the benzyl residue via different linkers resulting in PSB-19416 (14b, K-i 12.6 nM) and PSB-18332 (14a, K-i 2.98 nM) as fluorescent high-affinity probes for CD73. These compounds are anticipated to become useful tools for biological studies, drug screening, and diagnostic applications.



Last updated on 2024-26-11 at 23:45